Novartis 'completely committed' to Sandoz, has no split-off plan

Swiss drugmaker Novartis is "completely committed" to its $10 billion-per-year Sandoz generics business, a spokesman said on Thursday, after a newspaper reported Chief Executive Vas Narasimhan planned to split the unit off.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news